1. Home
  2. JQC vs IART Comparison

JQC vs IART Comparison

Compare JQC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

JQC

Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

HOLD

Current Price

$5.06

Market Cap

753.9M

Sector

Finance

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$11.30

Market Cap

877.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JQC
IART
Founded
2003
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
753.9M
877.1M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
JQC
IART
Price
$5.06
$11.30
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
$15.00
AVG Volume (30 Days)
714.6K
713.9K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
11.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,642,966,000.00
Revenue This Year
N/A
$3.26
Revenue Next Year
N/A
$2.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.99
52 Week Low
$4.82
$10.60
52 Week High
$5.65
$25.45

Technical Indicators

Market Signals
Indicator
JQC
IART
Relative Strength Index (RSI) 42.15 44.47
Support Level $5.02 $10.60
Resistance Level $5.14 $11.33
Average True Range (ATR) 0.04 0.54
MACD -0.01 0.03
Stochastic Oscillator 10.00 54.81

Price Performance

Historical Comparison
JQC
IART

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Share on Social Networks: